Systematic Reviews
Copyright ©The Author(s) 2017.
World J Meta-Anal. Dec 26, 2017; 5(6): 150-166
Published online Dec 26, 2017. doi: 10.13105/wjma.v5.i6.150
Table 6 Study characteristics and outcomes of prophylactic mesh placement of parastomal hernia n (%)
Ref.No. Patients (completed follow-up)
Type of stomaMaterial; techniqueParastomal hernia1
Wound infection
Mesh infection
Other3
Mor-talityFollow-up (mo)
MeshNo meshMeshNo meshMeshNo meshMeshMeshNo mesh
Târcoveanu et al[44]2022C: 42O: 42; Sublay; PP06 (27)02 (9)09 (45)11 (50)09 (median)
Ventham et al[63]1724C: 42O: 42; Sublay; PP6 (35)13 (54)2 (12%)1 (4)NS00012
López-Cano et al[40]19 (18)17 (16)C: 36L: 36; IPOM; SB; Proceed9 (50)15 (94)8 (44)3 (19)016 (89)5 (31)12 (3)12
Hauters et al[16]20-C: 20L: 17 O: 3; IPOM; SB: 20; PCM1 (5)-0-06 (30)-024
Figel et al[62]16-C: 16O: 16; IPOM; SB: 12; K: 4; Surgisis0-0-0NS-038 (median)
Janson et al[64]25-C: 25L: 25; Sublay; ULTRAPRO3 (15)-2 (8)-01 (4)-019
Jänes et al[42]75 (61)18 (12)C: 79 I: 14O: 93; Sublay; ULTRAPRO8 (13)8 (67)6 (8)4 (22)00052 (5)15
Serra-Aracil et al[6]2727C: 54O: 54; Sublay; ULTRAPRO6 (22)12 (44)4 (15)4 (15)01 (4)1 (4)029
Vijayasekar et al[45]42-C: 33 I: 9O: 42; Sublay; PP4 (10)-1 (2)-01 (2)-031
Jänes et al[43]27 (15)27 (21)C:54O: 54; Sublay; Vypro2 (13)17 (81)00000065
Hammond et al[68]1010NSO: 20; Sublay; Permacol03 (30)0000006.5
Hammond et al[21]15-NSO: 15; Onlay: 6; Sublay 9; Permacol1 (7)-NS-NSNS-07 (median)
Berger[39]25 (24)-C: 24 I: 1L: 6, O: 19; IPOM; K; DynaMesh0-0-00-12 (4)11
Marimuthu et al[46]18-NSO: 18; Sublay; Surgipro0-1 (6)-01 (6)-016
Gögenur et al[22]25 (24)-C: 25O: 25; Sublay; StomaMesh2 (8)-4 (17)-06 (25)-12 (4)12
Vierimaa et al[23]42 (35)41 (32)C: 83L: 83; IPOM; K; DynaMesh5 (14)12 (38)1 (3)2 (6)NS9 (21)10 (24)12 (1)12
Fleshman et al[20]55 (49)58 (53)C: I:23/ C:35 I: I:19/ C:36O: 113; Sublay; STRATTICE6 (12)7 (136)2 (4)3 (6)021 (38)30 (52)112 (10)24
Williams et al[41]22 (21)11C: I:4/ C:7 I: I:11/ C:11I: O = 18 L = 4 C: O = 11 SMART Onlay; Permacol4 (19)8 (73)NSNS02 (9)012 (3)I: 18 C: 9
Weighted pooled %; (95%CI)11.5% (7.1-16.8)51.5% (33.7-69.1)6.90% (3.6-11.1)9.30% (4.8-15.1)0% (0-2.0) FE14.20% (5.5-26.0)13.80% (3.0-30.7)2.6% (1.3-4.4)